Top Resources On Addiction Treatment Services

As selected by the OPEN MINDS Market Intelligence Team

  • The Framework For A Marketing Strategy For Addiction Treatment Programs

    Executive Briefing | April 17, 2017
    Medicaid is currently the primary payer for behavioral health treatment – both mental health and addictive disorders – paying about $54 billion in 2014, or 24% of the total $220 billion of U.S. behavioral health spending (see Behavioral Health...
  • Increased Medicaid Opioid Addiction Treatment Capacity In Southeastern States Needed

    News Report | April 16, 2017
    Opioid treatment program (OTP) capacity to accept Medicaid beneficiaries in the southeastern United States is lower than needed to meet estimated demand based on the prevalence of opioid use disorder and county-level treatment admissions in that region. The counties...
  • U.S. Drug Overdose Rate Climbs; Heroin & Prescription Opioids Top The List

    News Report | April 9, 2017
    Between 2010 and 2015, the age-adjusted drug overdose death rate increased by 31%, from 12.4 per 100,000 in 2010 to 16.3 per 100,000 in 2015. The percentage of overdose deaths due to heroin and prescription opioids increased from 57% in...
  • Access To Medication Assisted Treatment For Opioid Addiction

    Market Intelligence Report | April 6, 2017
    Medication assisted treatment (MAT) uses a combination of prescription drugs and behavioral treatment to address addiction, and is an important tool in combating the overuse of both legal and illegal opioids. To assess the market opportunity of MAT services,...
  • 40% Of People Receiving Buprenorphine Also Take Other Opioids

    News Report | March 12, 2017
    More than 40% of people being treated with buprenorphine for an opioid use disorder are prescribed non-buprenorphine opioids during the treatment episode. After completing buprenorphine treatment, two-thirds filled a non-buprenorphine opioid prescription. These findings were reported in “Non-buprenorphine opioid...
  • Outcomes Of Opioid MAT, Telepsychiatry Equivalent To Face-To-Face Treatment

    News Report | February 19, 2017
    Treatment outcomes for people receiving medication-assisted treatment (MAT) with buprenorphine for opioid addiction were equivalent for those who received counseling via telehealth technology and those who attended in-person office visits for counseling. Those who received face-to-face counseling had no...
  • FDA Approves Low-Dose Narcan Nasal Spray To Reverse Opioid Overdose

    News Report | February 19, 2017
    On January 25, 2017, the U.S. Food and Drug Administration (FDA) approved a new 2 milligram (mg) intranasal spray of Narcan (naloxone hydrochloride) developed by Adapt Pharma. The 2 mg dose is approved for use by family members and...
  • Two-Thirds Of Buprenorphine-Certified Physicians Have Waiting Lists

    News Report | January 31, 2016
    About 66.3% of physicians holding waivers to prescribe buprenorphine during outpatient addiction treatment say consumer demand for treatment exceeds the waiver’s 100-patient limit, according to a survey conducted by the American Society of Addiction Medicine (ASAM). Currently, physicians must...
  • How Much Residential Addiction Treatment Capacity Do We Need?

    Executive Briefing | February 18, 2017
    The opioid epidemic has gotten a lot of attention both within the behavioral health community, but also by the general public — The Obamacare Repeal ‘Could Be A Disaster’ For States Fighting The Opioid Epidemic and Opioid Addiction –...
  • Addiction & Hospital Utilization – The Endless Loop?

    Executive Briefing | February 6, 2017
    Recently we’ve had a lot of coverage of addiction in general, and opioid addiction in particular. These are just a few of the articles that we’ve published in the last 30 days: Survey Finds State Medicaid Addiction Treatment Benefits...
  • Survey Finds State Medicaid Addiction Treatment Benefits Vary Widely

    News Report | January 29, 2017
    Addiction treatment benefits covered by state Medicaid programs varied widely during 2013 and 2014.  Eighteen states and the District of Columbia provided comprehensive coverage of medications used to treat opioid use disorder and coverage for inpatient, residential, and outpatient treatment...
  • Opioid-Related Hospitalizations Up 64% Nationwide From 2005 To 2014

    News Report | January 22, 2017
    Between 2005 and 2014, there was a 64.1% cumulative increase in the rate of opioid-related inpatient stays, from 136.8 per 100,000 in 2005 to 224.6 per 100,000 in 2014. This represents an annual average growth rate of 5.7%. During...
  • SAMHSA Training To Allow Nurse Practitioners & Physician Assistants To Prescribe Buprenorphine

    News Report | December 4, 2016
    On November 16, 2016, the federal Substance Abuse and Mental Health Services Administration (SAMHSA) announced it was opening buprenorphine prescriber training to nurse practitioners (NPs) and physician assistants (PAs). Previously, only physicians could participate in the training to prescribe...


Support Request

Need help now?

Call our toll-free phone number 877-350-6463